跳至主要内容
临床试验/DRKS00017537
DRKS00017537招募中未知

Effect of Calanus® Oil on glucose tolerance and insulin resistance in prediabetics – proof-of-principle - CADIP

Institut für Lebensmittelwissenschaft und Humanernährung0 个研究点目标入组 60 人开始时间: 2019年8月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • o Age: 40-75 years
  • o Willingness to take part on the whole study procedure
  • o Willingness to take the capsules over 16 weeks
  • o Stable weight since at least half a year (±3 kg)
  • o ADA Prediabetes Screening Test Score > 5
  • o Glucose levels 2 hours after 75-g OGTT >140-199 mg/dl
  • o Omnivorous diet

排除标准

  • o Severe chronic diseases (i.e., diagnosed diabetes, cardiovascular disease, liver disease, renal insufficiency, cancer)
  • o Chronic diseases involving the immune system (i.e., Crohn’s disease, colitis ulcerosa, rheumatoid arthritis, multiple sclerosis)
  • o Use of any medication and food ingredients affecting blood glucose control and insulin sensitivity (including isolated dietary fiber such as guar gum, pectins, psyllium)
  • o consumption of n3 fatty acid supplements
  • o Permanent use of immunosuppressive drugs (corticoids etc.)
  • o Abuse of alcohol and drugs
  • o Participation in another clinical study within the last 30 days
  • o Pregnancy
  • o Hypertonia: > 160 mmHg systolic blood pressure and > 100 mmHg diastolic blood pressure
  • o Planned operation in the next 3 months

研究者

相似试验